SilverHawk EXL catheter launched in the US:
This article was originally published in Clinica
Executive Summary
FoxHollow Technologies has launched its SilverHawk EXL plaque excision device in the US. The product is designed to remove atherosclerotic tissue that blocks arteries in the lower leg of patients suffering from peripheral artery disease (PAD). It is an advance on the currently-marketed SilverHawk product line in that it has a lengthened nosecone and includes Redwood City, California-based FoxHollow's micro efficient compression (MEC) technology - laser-drilled micro vent holes in the tip of the catheter. These vents provide more space for the collection of tissue in the tip of the device. It is expected to be CE marked for sale in Europe by the end of this quarter, and will be marketed as part of the firm's integrated commercial effort with Plymouth, Minnesota-based ev3, once the firms' merger closes at the end of this year (see Clinica No 1266, p 3).